Status: current, Defined. Date: 31-Dec 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1742281000168115 | paliperidone 175 mg / 0.875 mL modified release injection, 1 x 0.875 mL syringe (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1742291000168117 | paliperidone 175 mg/0.875 mL modified release injection, 0.875 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| paliperidone 175 mg/0.875 mL modified release injection, 0.875 mL syringe | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| paliperidone 175 mg/0.875 mL modified release injection, 0.875 mL syringe | has MPUU | paliperidone 175 mg/0.875 mL modified release injection, syringe | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trevicta 175 mg/0.875 mL modified release injection, 0.875 mL syringe | Is a | True | paliperidone 175 mg/0.875 mL modified release injection, 0.875 mL syringe | Inferred relationship | Some | |
| Invega Trinza (paliperidone 175 mg / 0.875 mL) modified release injection, 1 x 0.875 mL syringe (trade product pack) | Is a | True | paliperidone 175 mg/0.875 mL modified release injection, 0.875 mL syringe | Inferred relationship | Some |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR